Callio Therapeutics Intent-to-Use Trademark - Scientific R&D Services
Summary
USPTO published Callio Therapeutics' intent-to-use trademark application (TM99357982) for Class 042 services covering scientific R&D, pharmaceutical development, drug discovery, and custom manufacturing. The application was filed on August 26, 2025. Callio Therapeutics seeks to register trademarks related to scientific research and therapeutic development services for oncology and immunology treatments.
What changed
USPTO published Callio Therapeutics' intent-to-use trademark application for Class 042 services, covering research and development in pharmaceuticals, biologics, chemistry, protein engineering, antibody-drug conjugates, multispecific antibodies, and engineered antibodies for oncology and immunology applications. The application also covers drug discovery, custom design, and development services for therapeutic agents, as well as custom manufacturing of pharmaceuticals for medical use.
Businesses using similar trademarks in Class 042 scientific and technological services should review the application to assess potential conflicts. Third parties have a standard opposition period to challenge the registration. The applicant, Callio Therapeutics, is a pharmaceutical and biotechnology company focused on oncology therapeutics. No immediate compliance action is required for unrelated parties, but trademark owners should verify their existing registrations do not overlap with the claimed services.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
CALLIO THERAPEUTICS
Intent to Use TM99357982 Kind: intenttouse Apr 01, 2026
Abstract
Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials; Pharmaceutical and biological preparations; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology; Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
Filing Date
2025-08-26
Related changes
Get daily alerts for USPTO Trademarks - Technology Services (Class 042)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Technology Services (Class 042) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.